Moderna vaccine

Decision based on clinical trial data that showed booster triggered 'a strong immune response'

Vaccine candidate would be first to be made based on widely used vaccine without assistance and approval of developer

Moderna's vaccine was 95% effective at preventing hospitalization compared with 80% for Pfizer, 60% for J&J

Suspension comes as Japan battles its worst wave of Covid-19 yet driven by Delta variant

The unequal rollout of Covid vaccines is creating a two-tier pandemic that is leaving developing nations behind

Arrival of 3 million doses is in addition to 2.5m doses Washington donated earlier this month, says official statement

Pfizer/BioNTech, mRNA vaccine protects not only against the original virus strain but also against worrisome variants

Pfizer/BioNTech vaccine is effective at preventing severe disease in people who have diabetes and heart condition

According to the EU agency, over 7 million people received the product of the Johnson & Johnson pharma company

Surgeons worldwide have been performing lung transplants in Covid-19 survivors with irreversible lung damage

Company says the two-dose regimen of vaccine was still expected to be protective against the variants detected to date

Moderna expects immunity from its vaccine to protect against the variants

It has been found to have an efficacy of 94.1 percent in a clinical trial involving 30,000 people

Claims that the vaccine is highly efficacious, and can play a major part in turning around this pandemic

Fauci says I would have been satisfied with 70 percent, but a 94.5 percent effective vaccine is stunningly impressive